(CNN)Utah health officials said Friday that the death of an elderly patient at the end of June was related to the Zika virus, the first Zika-related death in the continental United States. The unidentified resident of Salt Lake County had traveled to an undisclosed destination where the virus is circulating.
The Gulf Coast may know hurricanes, but this year the region of 60 million people could find itself unprepared and at ground zero for a different type of storm: a mosquito-borne Zika epidemic.
A look at the region's urban hubs, small towns and rural outposts shows a patchwork of preparedness. Cities such as Houston have robust plans in place, while smaller towns, such as Corpus Christi, Texas, struggle with fewer resources.
The Gulf Coast's steamy climate, abundant mosquitoes and international airports create an environment ripe for the mosquito-borne...
Experimental Zika is 'promising': New drug 'induces robust and durable immune responses' against virus
- Vaccine in development has shown 'promising' results in mice, trials show
- Experts say drug induced 'robust and durable immune response' to Zika
- There is currently no vaccine to protect people from the virus
- At least 15 companies and groups are currently racing to develop one
The 21st Century Cures Act bill passed in the U.S. House of Representatives this summer… and the Senate vote is coming up soon. We can only hope they care more about us than about their friends in the pharmaceutical industry… but that seems doubtful.
This bill is supposed to be about innovation, hope, and speeding up approvals for the “next generation of cures.” But what it’s really about is cutting costs for pharmaceutical companies, and putting more new drugs and devices on the shelves, much faster than ever before.
We already know that many...
- Last year’s flu shot was a dismal failure, with an effectiveness rate of only 23% overall, leading the CDC to blame the flop on the changing virus. It was even less effective for adults, protecting only 12% of adults 18-49, and 14% in people over age 50.
- Effectiveness is hit or miss, with overall success rates throughout the past ten years topping out at 60%, and bottoming out at a paltry 10%.
- Flu viruses evolve and mutate constantly, making it nearly impossible for a vaccine to ever match...